233 related articles for article (PubMed ID: 23958452)
1. CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.
Di Prisco S; Merega E; Milanese M; Summa M; Casazza S; Raffaghello L; Pistoia V; Uccelli A; Pittaluga A
Neuropharmacology; 2013 Dec; 75():337-46. PubMed ID: 23958452
[TBL] [Abstract][Full Text] [Related]
2. Functional adaptation of presynaptic chemokine receptors in EAE mouse central nervous system.
Di Prisco S; Merega E; Pittaluga A
Synapse; 2014 Nov; 68(11):529-35. PubMed ID: 25092801
[TBL] [Abstract][Full Text] [Related]
3. Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis.
Bonfiglio T; Olivero G; Vergassola M; Di Cesare Mannelli L; Pacini A; Iannuzzi F; Summa M; Bertorelli R; Feligioni M; Ghelardini C; Pittaluga A
Neuropharmacology; 2019 Feb; 145(Pt A):75-86. PubMed ID: 29402503
[TBL] [Abstract][Full Text] [Related]
4. Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis.
Marte A; Cavallero A; Morando S; Uccelli A; Raiteri M; Fedele E
J Neurochem; 2010 Oct; 115(2):343-52. PubMed ID: 20649849
[TBL] [Abstract][Full Text] [Related]
5. Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction.
Di Prisco S; Merega E; Lanfranco M; Casazza S; Uccelli A; Pittaluga A
Br J Pharmacol; 2014 May; 171(9):2457-67. PubMed ID: 24528439
[TBL] [Abstract][Full Text] [Related]
6. RANTES-mediated control of excitatory amino acid release in mouse spinal cord.
Di Prisco S; Summa M; Chellakudam V; Rossi PI; Pittaluga A
J Neurochem; 2012 May; 121(3):428-37. PubMed ID: 22385043
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
Bonfiglio T; Olivero G; Merega E; Di Prisco S; Padolecchia C; Grilli M; Milanese M; Di Cesare Mannelli L; Ghelardini C; Bonanno G; Marchi M; Pittaluga A
PLoS One; 2017; 12(1):e0170825. PubMed ID: 28125677
[TBL] [Abstract][Full Text] [Related]
8. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
9. Antibody/receptor protein immunocomplex in human and mouse cortical nerve endings amplifies complement-induced glutamate release.
Merega E; Prisco SD; Severi P; Kalfas F; Pittaluga A
Neurosci Lett; 2015 Jul; 600():50-5. PubMed ID: 26049008
[TBL] [Abstract][Full Text] [Related]
10. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
13. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
14. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
15. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
16. Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis.
Cid MP; Vilcaes AA; Rupil LL; Salvatierra NA; Roth GA
Neuroscience; 2011 Aug; 189():337-44. PubMed ID: 21635939
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic, release-regulating mGlu2 -preferring and mGlu3 -preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
Di Prisco S; Merega E; Bonfiglio T; Olivero G; Cervetto C; Grilli M; Usai C; Marchi M; Pittaluga A
Br J Pharmacol; 2016 May; 173(9):1465-77. PubMed ID: 26791341
[TBL] [Abstract][Full Text] [Related]
18. Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis.
Olivero G; Taddeucci A; Vallarino G; Trebesova H; Roggeri A; Gagliani MC; Cortese K; Grilli M; Pittaluga A
Br J Pharmacol; 2024 Jun; 181(12):1812-1828. PubMed ID: 38369641
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the clinical scoring and demyelination in central nervous system with total antioxidant capacity of plasma during experimental autoimmune encephalomyelitis development in mice.
Zargari M; Allameh A; Sanati MH; Tiraihi T; Lavasani S; Emadyan O
Neurosci Lett; 2007 Jan; 412(1):24-8. PubMed ID: 17157437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
